Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA.Weight loss injections have become incredibly popular in the ...

WeightWatchers has turned its back on its traditional business model and has caved to peddling the weight loss drugs that ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Due to its role in managing diabetes, Ozempic, the brand name for the medication semaglutide, is gaining a lot of attention.

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Curious about Ozempic benefits? Here’s who could benefit from using these medications—and why they’re not just for weight ...

Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

"MEDVi," a sketchy online market for GLP-1 drugs, is using AI to spin up terrible ads — and, insidiously, to deepfake ...